Sirolimus- or paclitaxel-eluting stents to prevent coronary artery restenosis

Author： Doggrell Sheila A  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.5, Iss.11, 2004-11, pp. : 2209-2220

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sirolimus- or paclitaxel-eluting stents for coronary artery revascularisation

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 2, 2006-02 ,pp. : 225-228

Informa Healthcare

Access to resources Recommend Favorite

Sirolimus- versus paclitaxel-eluting stents in patients with stenosis in a native coronary artery

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 6, 2004-06 ,pp. : 1431-1434

Informa Healthcare

Access to resources Recommend Favorite

A polymer-free, sirolimus-eluting stent is as effective as a standard, polymer-based, paclitaxel-eluting stent in the prevention of coronary artery restenosis

By  

Inpharma, Vol. 1, Iss. 1530, 2006-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Paclitaxel-eluting stents reduce restenosis

By  

Inpharma, Vol. 1, Iss. 1383-1384, 2003-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Paclitaxel-eluting stents reduce restenosis

By  

Inpharma, Vol. 1, Iss. 1385, 2003-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite